Overview

Evaluating AGuIX® Nanoparticles in Combination With Stereotactic Radiation for Brain Metastases

Status:
Terminated

Trial end date:
2021-02-24

Target enrollment:

Participant gender:

Summary

This study evaluates the clinical impact of AGuIX® nanoparticles in combination with Fractionated Stereotactic Radiation in oligo brain metastases.

Phase:

Phase 2

Details

Lead Sponsor:

Centre Leon Berard